Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine P Goyette, C Labbé, TT Trinh, RJ Xavier, JD Rioux Annals of medicine 39 (3), 177-199, 2007 | 160 | 2007 |
GWA studies: rewriting the story of IBD ML Budarf, C Labbé, G David, JD Rioux Trends in Genetics 25 (3), 137-146, 2009 | 123 | 2009 |
Epigenetic regulation in Parkinson’s disease C Labbé, O Lorenzo-Betancor, OA Ross Acta neuropathologica 132, 515-530, 2016 | 102 | 2016 |
Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study N Lassau, L Chapotot, B Benatsou, V Vilgrain, M Kind, J Lacroix, M Cuinet, ... Investigative radiology 47 (12), 711-716, 2012 | 88 | 2012 |
Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP‐C S Koga, KA Josephs, K Ogaki, C Labbé, RJ Uitti, N Graff‐Radford, ... Movement Disorders 31 (5), 653-662, 2016 | 74 | 2016 |
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders K Ogaki, S Koga, MG Heckman, FC Fiesel, M Ando, C Labbé, ... Neurology 85 (23), 2016-2025, 2015 | 64 | 2015 |
Analysis of COQ2gene in multiple system atrophy K Ogaki, S Fujioka, MG Heckman, S Rayaprolu, AI Soto-Ortolaza, ... Molecular neurodegeneration 9, 1-9, 2014 | 52 | 2014 |
Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology MG Heckman, RR Brennan, C Labbé, AI Soto, S Koga, MA DeTure, ... JAMA neurology 76 (6), 710-717, 2019 | 48 | 2019 |
Role for the microtubule-associated protein tau variant p. A152T in risk of α-synucleinopathies C Labbé, K Ogaki, O Lorenzo-Betancor, AI Soto-Ortolaza, RL Walton, ... Neurology 85 (19), 1680-1686, 2015 | 45* | 2015 |
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies C Labbé, MG Heckman, O Lorenzo-Betancor, AI Soto-Ortolaza, ... Alzheimer's & Dementia 12 (12), 1297-1304, 2016 | 43 | 2016 |
GWAS risk factors in Parkinson’s disease: LRRK2 coding variation and genetic interaction with PARK16 AI Soto-Ortolaza, MG Heckman, C Labbé, DJ Serie, A Puschmann, ... American journal of neurodegenerative disease 2 (4), 287, 2013 | 42 | 2013 |
Investigating the role of FUS exonic variants in essential tremor C Labbé, AI Soto-Ortolaza, S Rayaprolu, AM Harriott, AJ Strongosky, ... Parkinsonism & related disorders 19 (8), 755-757, 2013 | 41 | 2013 |
Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder J Li, JA Ruskey, I Arnulf, Y Dauvilliers, MTM Hu, B Högl, CS Leblond, ... Movement Disorders 33 (6), 1016-1020, 2018 | 36 | 2018 |
LRRK2 variation and dementia with Lewy bodies MG Heckman, AI Soto-Ortolaza, MYS Contreras, ME Murray, O Pedraza, ... Parkinsonism & related disorders 31, 98-103, 2016 | 36 | 2016 |
MAST3: a novel IBD risk factor that modulates TLR4 signaling C Labbé, P Goyette, C Lefebvre, C Stevens, T Green, MK Tello-Ruiz, ... Genes & Immunity 9 (7), 602-612, 2008 | 36 | 2008 |
PCNT point mutations and familial intracranial aneurysms O Lorenzo-Betancor, PR Blackburn, E Edwards, R Vázquez-do-Campo, ... Neurology 91 (23), e2170-e2181, 2018 | 32 | 2018 |
MAPT haplotype diversity in multiple system atrophy C Labbé, MG Heckman, O Lorenzo-Betancor, ME Murray, K Ogaki, ... Parkinsonism & related disorders 30, 40-45, 2016 | 31 | 2016 |
Genome-wide Expression Profiling Implicates a MAST3-Regulated Gene Set in Colonic Mucosal Inflammation of Ulcerative Colitis Patients C Labbé, G Boucher, S Foisy, A Alikashani, H Nkwimi, G David, ... Inflammatory bowel diseases 18 (6), 1072-1080, 2012 | 31 | 2012 |
Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease B Shannon, A Soto-Ortolaza, S Rayaprolu, HD Cannon, C Labbé, ... Neurobiology of aging 35 (8), 1958. e1-1958. e2, 2014 | 28 | 2014 |
Association studies of sporadic Parkinson’s disease in the genomic era C Labbé, O A Ross Current genomics 15 (1), 2-10, 2014 | 28 | 2014 |